Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stem Cell Research

  Free Subscription


Articles published in Transfusion

Retrieve available abstracts of 34 articles:
HTML format



Single Articles


    July 2022
  1. HOWELL A, Letcher B, Murphy K, Elmoazzen H, et al
    Automated closed volume reduction process for apheresis stem cell grafts: From development to clinical implementation.
    Transfusion. 2022 Jul 19. doi: 10.1111/trf.17022.
    PubMed     Abstract available


  2. FRANKE GN, Pfannes R, Heyn S, Bruckner M, et al
    Analysis of stem cell collections in adult patients with Ewing sarcoma.
    Transfusion. 2022 Jul 8. doi: 10.1111/trf.17013.
    PubMed     Abstract available


    June 2022
  3. TREPANIER P, Fournier D, Simard C, Fontaine MJ, et al
    Multicenter evaluation of the IL-3-pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study.
    Transfusion. 2022 Jun 30. doi: 10.1111/trf.16997.
    PubMed     Abstract available


    May 2022
  4. ALSTON E, Xu X, Nikiforow S, Stowell S, et al
    Unusual non-platelet predominant clumping in a hematopoietic progenitor cell apheresis collection bag.
    Transfusion. 2022;62:931-932.
    PubMed    


    April 2022
  5. PATEL KA, Patel N, Kim GH, Chape LS, et al
    Validation of automated fluorescent-based technology for measuring total nucleated cell viability of hematopoietic progenitor cell products.
    Transfusion. 2022;62:848-856.
    PubMed     Abstract available


    March 2022
  6. KONDO T, Fujii N, Fujii K, Sumii Y, et al
    Low hematocrit reduces the efficiency of CD34(+) cell collection when using the Spectra Optia continuous mononuclear cell collection procedure.
    Transfusion. 2022 Mar 24. doi: 10.1111/trf.16856.
    PubMed     Abstract available


  7. REICH-SLOTKY R, Vasovic LV, Land KJ, Halpenny M, et al
    Cryopreserved hematopoietic stem/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project team.
    Transfusion. 2022;62:651-662.
    PubMed     Abstract available


    February 2022
  8. SIDDIQUI I, Shmookler A, Biller E, Hardy T, et al
    Impact of mobilization regimen on multiday collection of peripheral blood CD34+ cells by large volume leukapheresis.
    Transfusion. 2022 Feb 25. doi: 10.1111/trf.16842.
    PubMed     Abstract available


  9. FINGRUT WB, Chen AC, Green M, Weiss JT, et al
    Development and evaluation of checklists to support the recruitment of committed hematopoietic stem cell donors.
    Transfusion. 2022 Feb 19. doi: 10.1111/trf.16827.
    PubMed     Abstract available


    January 2022
  10. RUBIO-AZPEITIA E, Perez-Corral AM, Dorado-Herrero N, Monsalvo S, et al
    Clinical grade production of IL-15 stimulated NK cells for early infusion in adult AML patients undergoing haploidentical stem cell transplantation with post-transplant cyclophosphamide.
    Transfusion. 2022 Jan 13. doi: 10.1111/trf.16790.
    PubMed     Abstract available


    December 2021
  11. VUCINIC V, Jentzsch M, Leiblein S, Bach E, et al
    Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).
    Transfusion. 2021 Dec 10. doi: 10.1111/trf.16761.
    PubMed     Abstract available


    November 2021
  12. DIANA JS, Manceau S, Leblanc T, Magnani A, et al
    A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy.
    Transfusion. 2021 Nov 9. doi: 10.1111/trf.16721.
    PubMed     Abstract available


  13. LIVINGSTON J, Di-Mola M, Lowry J, Ruse N, et al
    Peripheral venous catheter collection of immune effector cells and hematopoietic stem cells is feasible and safe in older pediatric patients.
    Transfusion. 2021 Nov 9. doi: 10.1111/trf.16717.
    PubMed     Abstract available


    September 2021
  14. ANU P, Antti T, Raija S, Marja P, et al
    Comparison of CD34(+) cell mobilization, blood graft cellular composition, and post-transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low-dose cyclophosphamide: A prospective multicenter study.
    Transfusion. 2021 Sep 9. doi: 10.1111/trf.16645.
    PubMed     Abstract available


  15. AVECILLA ST, Boulad F, Yazdanbakhsh K, Sadelain M, et al
    Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.
    Transfusion. 2021;61:2775-2781.
    PubMed     Abstract available


    August 2021
  16. TANHEHCO YC, Delgado AC
    Red blood cell reduction of a sickle cell disease stem cell product.
    Transfusion. 2021 Aug 29. doi: 10.1111/trf.16633.
    PubMed    


  17. GOEL R, Nellis ME, Karam O, Hanson SJ, et al
    Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).
    Transfusion. 2021 Aug 29. doi: 10.1111/trf.16626.
    PubMed     Abstract available


  18. HUVAROVA L, Koristek Z, Jelinek T, Cerna L, et al
    Washing transplants with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patients' comfort.
    Transfusion. 2021;61:2430-2438.
    PubMed     Abstract available


    May 2021
  19. PHAM HP, Dormesy S, Wolfe K, Budhai A, et al
    Potentially modifiable predictors of cell collection efficiencies and product characteristics of allogeneic hematopoietic progenitor cell collections.
    Transfusion. 2021;61:1518-1524.
    PubMed     Abstract available


  20. JACOB RP, Walsh EM, Maslak PG, Giralt SA, et al
    A simplified CD34+ based preharvest prediction tool for HPC(A) collection.
    Transfusion. 2021;61:1525-1532.
    PubMed     Abstract available


    April 2021
  21. MCOMISH C
    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:1007-1009.
    PubMed    


    March 2021
  22. RENNERT W, Sobh L, Cormier K, Smith J, et al
    The impact of donor total estimated blood volume on nucleated cell yield in bone marrow harvests for hematopoietic stem cell transplantation.
    Transfusion. 2021 Mar 25. doi: 10.1111/trf.16374.
    PubMed     Abstract available


  23. GASIOR M, Ferreras C, de Paz R, Bueno D, et al
    The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naive T-cell-depleted allogeneic stem cell transplantation.
    Transfusion. 2021 Mar 13. doi: 10.1111/trf.16354.
    PubMed     Abstract available


  24. CUZZUBBO D, Pegoraro F, Frenos S, Casini T, et al
    Planned haematopoietic stem cell transplantation in a 17-month-old patient with high-risk acute myeloid leukaemia and persistent SARS-CoV-2 infection.
    Transfusion. 2021 Mar 8. doi: 10.1111/trf.16361.
    PubMed    


  25. MCOMISH C
    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:665-668.
    PubMed    


    February 2021
  26. BELISARIO AR, da Costa Funes AP, Luz JR, de Almeida Costa L, et al
    Influence of laboratory procedures on postthawing cell viability and hematopoietic engraftment after autologous peripheral blood stem cell transplantation.
    Transfusion. 2021 Feb 10. doi: 10.1111/trf.16289.
    PubMed     Abstract available


  27. YATES B, Molloy E, Dulau-Florea A, Braylan R, et al
    Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
    Transfusion. 2021 Feb 2. doi: 10.1111/trf.16281.
    PubMed     Abstract available


    January 2021
  28. BHUNIA N, Abu-Arja R, Stanek JR, Shaw PJ, et al
    A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders.
    Transfusion. 2021 Jan 21. doi: 10.1111/trf.16260.
    PubMed     Abstract available


  29. KHAN J, Dunbar NM
    Time to stop worrying about ABO incompatible cryoprecipitate transfusions in adults.
    Transfusion. 2021;61:1-4.
    PubMed    


    December 2020
  30. LI EW, Lee A, Vaseghi-Shanjani M, Anagnostopoulos A, et al
    Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: Perspectives of the most-needed donors.
    Transfusion. 2020 Dec 2. doi: 10.1111/trf.16186.
    PubMed     Abstract available


    November 2020
  31. PARTANEN A, Turunen A, Valtola J, Pyorala M, et al
    Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study.
    Transfusion. 2020 Nov 27. doi: 10.1111/trf.16198.
    PubMed     Abstract available


    October 2020
  32. ENOK BONONG PR, Buteau C, Delage G, Tanner JE, et al
    Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study).
    Transfusion. 2020 Oct 22. doi: 10.1111/trf.16149.
    PubMed     Abstract available


  33. MONAGHAN M, Yi QL, Green M, Campbell T, et al
    Factors associated with registrant availability for unrelated adult donor hematopoietic stem cell donation: Analysis of the stem cell registry at Canadian Blood Services.
    Transfusion. 2020 Oct 21. doi: 10.1111/trf.16129.
    PubMed     Abstract available


  34. STEUER LV, Kondo AT, Cipolletta AN, Sakashita AM, et al
    Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Transfusion. 2020 Oct 14. doi: 10.1111/trf.16124.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: